InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: FDApproved post# 7311

Tuesday, 10/17/2017 3:14:52 PM

Tuesday, October 17, 2017 3:14:52 PM

Post# of 44784
Well that's not what I was saying. All I was mentioning is that the competition seems to have found a way to manufacture cells on a commercial scale. Not saying it's better or anything of that sort. Just that they can do this and are doing it for the biotech industry. I would imagine their technology is sufficient to satisfy the biotech companies and the regulatory bodies that oversee such things. That's why I thing any sort of partnership with Lonza is not in the works.

Also, that is why I will never understand why a company with a breakthrough technology like the 3d bioreactor with its many patents, didn't start trying to capitalize on their invention years ago. That's usually what companies do isn't it? Would have been ready for the boom in cell manufacturing for the biotech industry like Lonza is. 27% growth in the first half from there cell manufacturimg division. (Number may be off slightly as that's what I remember seeing when I checked). And this is just the beginning of the biotech boom that is coming.

Hence why I think these twins are over their head and truthfully don't understand how anyone doesn't see that. May work out great in our trials and all still be happy, but a giant opportunity was missed by our management. And we lost 2 years of product development time building out our almost idle facility. If a stockpiling contract does come, at least that will start the bioreactors going.